Literature DB >> 9838035

Intrastriatal and intraventricular injections of oligodeoxynucleotides in the rat brain: tissue penetration, intracellular distribution and c-fos antisense effects.

R Grzanna1, J R Dubin, G W Dent, Z Ji, W Zhang, S P Ho, P R Hartig.   

Abstract

We have determined the time course, the spatial spread in brain tissue, and the intracellular distribution of biotin- and fluorescein-labeled phosphorothioate oligodeoxynucleotides (ODNs) following single injections into the rat striatum or the lateral ventricle. These time and space parameters were correlated with the ability of c-fos phosphorothioate antisense ODNs to suppress the induction of Fos protein by cocaine. A rapid and dose-dependent tissue penetration of labeled ODNs was observed following either intrastriatal or intraventricular injections of a constant sample volume. Inspection of tissue sections by confocal microscopy uncovered a distinct change in the intracellular disposition of labeled ODNs during the 24 h post-injection period. At 1, 6 and 12 h, the vast majority of the fluorescent signal was confined to the interstitial spaces throughout the zone penetrated by ODNs. Neuronal nuclei displayed faint labeling along the outer portion of the nucleus at 1 and 6 h post-injection. At these time-points, ODNs were not detected in the cytoplasm. By 16 h, ODNs were barely detectable in the extracellular space and absent from neuronal nuclei. Instead, ODNs were seen in large cytoplasmic granules of neurons throughout the tissue zone penetrated by the ODNs. Experiments with intrastriatal injections of antisense ODNs to c-fos mRNA revealed Fos suppression between 3 and 12 h, but not at 16 and 24 h. This combined analysis has revealed that (1) restricted tissue penetration by ODNs limits their antisense effects on protein expression, and (2) depletion of extracellular ODNs and sequestration of c-fos antisense ODNs into large intracellular granules coincides with the loss of their biological activity. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9838035     DOI: 10.1016/s0169-328x(98)00238-1

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  8 in total

1.  Suppression of cortical NMDA receptor function prevents development of orientation selectivity in the primary visual cortex.

Authors:  A S Ramoa; A F Mower; D Liao; S I Jafri
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

2.  TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors.

Authors:  Yang Liu; Qing Wang; B K Kleinschmidt-DeMasters; Alex Franzusoff; Ka-yun Ng; Kevin O Lillehei
Journal:  J Neurooncol       Date:  2006-08-29       Impact factor: 4.130

3.  Steroid receptor coactivator 2 modulates steroid-dependent male sexual behavior and neuroplasticity in Japanese quail (Coturnix japonica).

Authors:  Neville-Andrew Niessen; Jacques Balthazart; Gregory F Ball; Thierry D Charlier
Journal:  J Neurochem       Date:  2011-09-28       Impact factor: 5.372

4.  Effects of antisense oligonucleotides on brain delta-opioid receptor density and on SNC80-induced locomotor stimulation and colonic transit inhibition in rats.

Authors:  L Negri; M Broccardo; R Lattanzi; P Melchiorri
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

5.  Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury.

Authors:  Z Yu; D Zhou; A J Bruce-Keller; M S Kindy; M P Mattson
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

6.  C-fos down-regulation inhibits testosterone-dependent male sexual behavior and the associated learning.

Authors:  Neville-Andrew Niessen; Jacques Balthazart; Gregory F Ball; Thierry D Charlier
Journal:  Eur J Neurosci       Date:  2013-07-29       Impact factor: 3.386

Review 7.  Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities.

Authors:  Viorel Simion; Wissem Deraredj Nadim; Helene Benedetti; Chantal Pichon; Severine Morisset-Lopez; Patrick Baril
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 8.  Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?

Authors:  João Casaca-Carreira; Yasin Temel; Sarah-Anna Hescham; Ali Jahanshahi
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.